GenTek Inc. Announces Early Termination of Hart-Scott-Rodino Act Waiting Period

PARSIPPANY, N.J., Oct. 8, 2009 (GLOBE NEWSWIRE) -- GenTek Inc. (Nasdaq:GETI)
today announced that on October 7, 2009, the Federal Trade Commission granted
early termination of the waiting period under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the "HSR Act"), in connection with the
previously announced tender offer for all outstanding shares of GenTek common
stock at a price of $38.00 per share, net to stockholders in cash, without
interest, commenced by ASP GT Acquisition Corp. ("ASP"), a wholly-owned
subsidiary of investment funds managed by American Securities LLC, a private
equity firm.

Accordingly, the condition to the tender offer that all statutory waiting
periods applicable to the tender offer under the HSR Act shall have expired or
been terminated has been satisfied. The tender offer continues to be conditioned
upon the other conditions described in the offer to purchase, the related letter
of transmittal and other tender offer materials that ASP filed with the
Securities and Exchange Commission on Sept. 29, 2009.

The tender offer is scheduled to expire at 12:00 midnight, New York City time,
on Tuesday, October 27, 2009, unless it is extended.

Moelis & Company is acting as financial advisor to GenTek and Latham & Watkins
LLP is legal counsel to GenTek.

About GenTek Inc.

GenTek provides specialty inorganic chemical products and valve actuation
systems and components for automotive and heavy duty/commercial engines. GenTek
operates over 50 manufacturing facilities and technical centers and has
approximately 1,100 employees. GenTek's 2,000-plus customers include many of the
world's leading manufacturers of cars and trucks, and heavy equipment, in
addition to global energy companies and water treatment facilities. Additional
information about the Company is available at www.gentek-global.com.

The GenTek Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=3295

Important Information about the Tender Offer

This press release is neither an offer to purchase nor a solicitation of an
offer to sell any securities. The solicitation and the offer to buy shares of
GenTek common stock has been made pursuant to an offer to purchase and related
materials that ASP filed with the U.S. Securities and Exchange Commission. At
the time the tender offer was commenced, on September 29, 2009, ASP filed a
Tender Offer Statement on Schedule TO with the U.S. Securities and Exchange
Commission, and thereafter on October 2, 2009, GenTek filed a
Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the
tender offer. THE TENDER OFFER STATEMENT (INCLUDING AN OFFER TO PURCHASE, A
RELATED LETTER OF TRANSMITTAL AND OTHER OFFER DOCUMENTS), AND THE SOLICITATION/
RECOMMENDATION STATEMENT, IN EACH CASE, AS AMENDED, CONTAIN IMPORTANT
INFORMATION THAT SHOULD BE READ CAREFULLY AND CONSIDERED BEFORE ANY DECISION IS
MADE WITH RESPECT TO THE TENDER OFFER. These materials have been sent free of
charge to all stockholders of GenTek. In addition, all of these materials are
available at no charge from the U.S. Securities and Exchange Commission through
its web site at www.sec.gov, from the Information Agent named in the tender
offer materials or from ASP.

Investors and security holders may also obtain free copies of these documents
that are filed with the U.S. Securities and Exchange Commission from GenTek at
www.gentek-global.com.

-0-
CONTACT: GenTek Inc.
Investor/Media Contact:
Thomas B. Testa
973-515-1885
IR@gentek-global.com